PMID- 16367933 OWN - NLM STAT- MEDLINE DCOM- 20060206 LR - 20181113 IS - 0009-9104 (Print) IS - 1365-2249 (Electronic) IS - 0009-9104 (Linking) VI - 143 IP - 1 DP - 2006 Jan TI - Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model. PG - 50-7 AB - Periodontitis is characterized by an accumulation of inflammatory cells in periodontal tissue and subgingival sites. Leukocytes play a major role in the host response to Porphyromonas gingivalis, a major aetiological agent of chronic periodontitis. Secretion of high levels of inflammatory mediators, including cytokines and prostaglandins, by leucocytes is believed to contribute to periodontal tissue destruction. The aim of this study was to investigate the inflammatory response of an ex vivo whole blood model to P. gingivalis stimulation. The production of interleukin-1 beta (IL-1beta), IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, tumour necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), IFN-gamma-inducible protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), Regulated on Activation Normal T cell Expressed and Secreted (RANTES) and prostaglandin E2 (PGE2) were quantified by enzyme-linked immunosorbent assays. P. gingivalis induced the secretion of the pro-inflammatory cytokines IL-1beta, TNF-alpha, IL-6 and IFN-gamma, the chemokines IL-8, RANTES and MCP-1 and the inflammatory mediator PGE2 in an ex vivo human whole blood model. The secretion levels were dependent on the strain and the infectious dose used. While the mediator profiles were comparable between six healthy subjects, a high interindividual variability in the levels of secreted mediators was observed. This study supports the view that P. gingivalis, by inducing high levels of inflammatory mediators from a mixed leucocyte population, can contribute to the progression of periodontitis. FAU - Bodet, C AU - Bodet C AD - Groupe de Recherche en Ecologie Buccale, Faculte de Medecine Dentaire, Universite Laval, Quebec City, Quebec, Canada. FAU - Chandad, F AU - Chandad F FAU - Grenier, D AU - Grenier D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Clin Exp Immunol JT - Clinical and experimental immunology JID - 0057202 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL5) RN - 0 (Cytokines) RN - 0 (Interleukin-1) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (Serum Albumin) RN - 0 (Tumor Necrosis Factor-alpha) RN - 82115-62-6 (Interferon-gamma) RN - K7Q1JQR04M (Dinoprostone) SB - IM MH - Analysis of Variance MH - Bacteriological Techniques/methods MH - Bacteroidaceae Infections/*immunology MH - Cells, Cultured MH - Chemokine CCL2/analysis MH - Chemokine CCL5/analysis MH - Cytokines/*analysis MH - Dinoprostone/analysis MH - Enzyme-Linked Immunosorbent Assay MH - Humans MH - Interferon-gamma/analysis MH - Interleukin-1/analysis MH - Interleukin-6/analysis MH - Interleukin-8/analysis MH - Periodontitis/*immunology MH - Porphyromonas gingivalis/metabolism/*physiology MH - Serum Albumin/metabolism MH - Species Specificity MH - Tumor Necrosis Factor-alpha/analysis PMC - PMC1809557 EDAT- 2005/12/22 09:00 MHDA- 2006/02/07 09:00 PMCR- 2007/01/01 CRDT- 2005/12/22 09:00 PHST- 2005/12/22 09:00 [pubmed] PHST- 2006/02/07 09:00 [medline] PHST- 2005/12/22 09:00 [entrez] PHST- 2007/01/01 00:00 [pmc-release] AID - CEI2956 [pii] AID - 10.1111/j.1365-2249.2005.02956.x [doi] PST - ppublish SO - Clin Exp Immunol. 2006 Jan;143(1):50-7. doi: 10.1111/j.1365-2249.2005.02956.x.